Autonomix Medical, Inc. Common Stock EBITDA for the Trailing 12 Months (TTM) ending December 31, 2024: USD -13.27 M

Autonomix Medical, Inc. Common Stock EBITDA is USD -13.27 M for the Trailing 12 Months (TTM) ending December 31, 2024, a 110.80% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • Autonomix Medical, Inc. Common Stock EBITDA for the Trailing 12 Months (TTM) ending December 31, 2023 was USD -6.29 M, a 1,057.17% change year over year.
Key Data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)